Entries of Uhlig, Jens on the publication server

Heinrich, Kathrin, Modest, Dominik Paul, Ricard, Ingrid, Fischer von Weikersthal, Ludwig, Decker, Thomas, Vehling-Kaiser, Ursula, Graeven, Ullrich, Uhlig, Jens, Schenk, Michael, Freiberg-Richter, Jens, Peuser, Bettina, Denzlinger, Claudio, Peveling genannt Reddemann, Christina, Giessen-Jung, Clemens, Stahler, Arndt, Held, Swantje, Jung, Andreas, Kirchner, Thomas, Stintzing, Sebastian and Heinemann, Volker (2019) Gender and survival benefit from initial irinotecan in metastatic colorectal cancer: Analysis of the XELAVIRI (AIOKRK0110) study. Journal of Clinical Oncology 37 (15_sup), p. 3559. Fulltext not available.

Modest, Dominik Paul, Fischer von Weikersthal, Ludwig, Decker, Thomas, Vehling-Kaiser, Ursula, Uhlig, Jens, Schenk, Michael, Freiberg-Richter, Jens, Peuser, Bettina, Denzlinger, Claudio, Peveling genannt Reddemann, Christina, Graeven, Ullrich, Schuch, Gunter, Schwaner, Ingo, Stahler, Arndt, Jung, Andreas, Kirchner, Thomas, Held, Swantje, Stintzing, Sebastian, Giessen-Jung, Clemens and Heinemann, Volker (2019) Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study—XELAVIRI (AIO KRK0110). Journal of Clinical Oncology 37 (1), pp. 22-32. Fulltext not available.